Response to "What is the Current Clinical Impact of the CYP2C:TG Haplotype?".
Document Type
Response or Comment
Publication Date
2-2024
Identifier
DOI: 10.1002/cpt.3093
Abstract
This article is linked to, “What is the Current Clinical Impact of the CYP2C:TG Haplotype?” by Ingelman-Sundberg, M., et al., Clin. Pharmacol. Ther. 115, 183 (2024). https://doi.org/10.1002/cpt.3094
Journal Title
Clinical pharmacology and therapeutics
Volume
115
Issue
2
First Page
184
Last Page
184
MeSH Keywords
Humans; Haplotypes; Cytochrome P-450 Enzyme System; Aryl Hydrocarbon Hydroxylases
Keywords
Haplotypes; Cytochrome P-450 Enzyme System; Aryl Hydrocarbon Hydroxylases
Recommended Citation
Zubiaur P, Leeder JS, Abad-Santos F, Gaedigk A. Response to "What is the Current Clinical Impact of the CYP2C:TG Haplotype?". Clin Pharmacol Ther. 2024;115(2):184. doi:10.1002/cpt.3093
COinS
